- Platform spans target selection through clinic
- Deep screening can uncover rare antibodies
- Supports historically difficult membrane protein targets
- Clinical manufacturing is integrated in-house
- Over 100 discovery programs completed
AbCellera
AI-enabled antibody discovery engine
SF7.68
SF Score editorial score across features, ease, and value, based on public reviews and product research. Learn more →
Pharma partners and antibody programs
Pharma partners and antibody programs
Best for
Pharma partners and antibody programs
Pricing
Custom
Free plan
Check vendor
SoftFinders Score
7.68 / 10
Overview
What is AbCellera?
AbCellera is an AI-enabled antibody discovery platform for pharma partners and antibody programs, combining high-throughput data with computational biology to support discovery.
- Research focus: It supports R&D and antibody development rather than guaranteeing clinical outcomes, with successful candidates still dependent on downstream validation and trials.
- Engagement model: Access typically runs through pharma partnerships rather than self-service subscriptions, making collaboration structure a buying consideration.
- Evaluation priorities: Buyers should assess data-access requirements, expected timelines to validated leads, program scope, and the cost structure across collaborations before committing.
- Commercial model: Pricing is sales-led and scoped per buyer rather than published, while engagement remains partnership and pipeline-led.
AbCellera is best assessed as a collaborative antibody-discovery engine whose fit depends on scientific objectives, partnership requirements, and economics.
KEY FEATURES
What you get out of the box
Deep single-cell screening of immune repertoires
Generates and ranks small molecule candidates
High-throughput functional antibody screening and assessment
Predicts and designs protein structures
Structure-guided antibody engineering and optimization
Connects biological and chemical knowledge sources
Developability profiling across biophysical assay panels
Screens compound libraries against targets
USE CASES
Where teams put it to work
Discover antibodies against complex membrane targets
Engineer multispecific T-cell engager candidates
Optimize leads for potency and developability
Advance antibodies through IND-enabling studies
Develop precision antibody-drug conjugate programs
Support partnered therapeutic antibody discovery programs
Editorial Take
What we like, and what to verify
- Specialized primarily around antibody-based medicines
- Access centers on strategic partnership arrangements
- Internal programs now receive greater focus
Screenshots
A look inside
Alternatives
Tools to consider next
Iktos SF 7.4
Why consider it
Generative chemistry and synthesis planning AI
Cradle SF 7.48
Why consider it
AI protein design for wet labs
Chai Discovery SF 7.28
Why consider it
Molecular structure prediction for discovery research
NOETIK SF 7.1
Why consider it
Spatial biology models for cancer targets
Generate Biomedicines SF 7.68
Why consider it
Generative protein design across modalities
Causaly SF 7.58
Why consider it
Biomedical evidence and reasoning for R&D
USER REVIEWS
AbCellera Reviews
Published user reviews are moderated and kept separate from the SoftFinders Score.
No published reviews yet.
Reviews from real users will appear here once published.
Used AbCellera?
Share your experience with other buyers.
FAQ